Novotech Sponsors BIO 2023 APAC Summit and the Endpoints Panel on Forging Biotech Ties with China
29 mai 2023 15h10 HE
|
Novotech
BOSTON, May 29, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO is sponsoring the BIO 2023 APAC Summit, and the Endpoints session on Forging New Biotech Ties with...
Novotech Sponsors Oncology Summit with eChina Health and Expert Panel on Drug Development Acceleration with Endpoints for ASCO 2023
25 mai 2023 17h27 HE
|
Novotech
CHICAGO, May 25, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO is sponsoring key oncology focussed expert events for ASCO: a pre-ASCO Summit with eChina Health, and...
Industry Survey Identifies Successful Biotech Clinical Trial Strategies
08 mai 2023 20h36 HE
|
Novotech
SYDNEY, Australia, May 08, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO conducted a survey of global biotech professionals, in partnership with Citeline, on their...
Novotech Joins Expert Panel at AACR for eChinaHealth Session on Collaborating with China’s Cancer Research Sector
13 avr. 2023 18h33 HE
|
Novotech
SYDNEY, Australia, April 13, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO joins oncology leaders at the eChinaHealth panelist session and dinner at AACR. The...
Novotech Team at BIO Europe to Share Benefits of Expanded Global Operations
07 mars 2023 01h35 HE
|
Novotech
SINGAPORE, March 07, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO will be at BIO Europe (March 20-22, 2023) to meet with clinical-stage biotechs and to share the...
Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends
03 mars 2023 00h27 HE
|
Novotech
SINGAPORE, March 03, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is convening an expert panel webinar with Endpoints...
Novotech Acquires European CRO – Strengthens Global Operations
12 janv. 2023 01h34 HE
|
Novotech
SINGAPORE, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important...
Novotech Acquires US-based Drug Development Consulting Firm, CBR International - Expands Drug Development and FDA Regulatory Expertise
09 janv. 2023 11h34 HE
|
Novotech
SINGAPORE, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR International, a global product development, clinical...
Novotech Acquires European CRO – Strengthens Global Operations
09 janv. 2023 11h33 HE
|
Novotech
SINGAPORE, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important...
Data Shows 50% of New Trials Have Sites in Asia Pacific
14 déc. 2022 20h06 HE
|
Novotech
SINGAPORE, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publication by GlobalData and Novotech found almost 50% of...